Tag: FDA

Complex Generic Formulations: Why Proving Bioequivalence Is So Hard

Dec, 17 2025| 0 Comments

Proving bioequivalence for complex generics like inhalers, creams, and injectables is far harder than for simple pills. Learn why standard tests fail, how reverse-engineering works, and what’s being done to bring affordable versions to market.